13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2019. See the latest, Q2 2026 →
Reported value
$477.16B
+7.6% on the quarter before
Positions
2,001
209 new · 221 sold out
Top 10
16.3%
of the value
Est. gain
+$34.25B
on stocks held all quarter
Est. return
+8.3%
on those stocks since Q3 2019
Positions as of Dec 31, 2019, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.
Largest buys
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$2.62BAdded · 0.7% → 1.4%+8,931,281 shares
- Mcdonalds Corp~$1.21BAdded · 0.7% → 0.9%+6,129,691 shares
- Progressive Corp Ohio~$1.13BAdded · 0.3% → 0.5%+15,541,142 shares
- Exelon Corporation~$981.1MAdded · 0.3% → 0.5%+21,520,378 shares
- Truist Finl Corp~$850.1MNew · 0.0% → 0.2%+15,094,850 shares
- Pfizer Inc~$743.6MAdded · 1.4% → 1.6%+18,979,451 shares
- Texas Instruments~$688.6MAdded · 0.1% → 0.3%+5,367,378 shares
- Unitedhealth Group Inc~$666.8MAdded · 1.5% → 2.0%+2,268,020 shares
- Eli Lilly~$615.6MAdded · 1.0% → 1.2%+4,683,710 shares
- Becton Dickinson & Co~$562.5MAdded · 0.0% → 0.1%+2,068,082 shares
Largest sells
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bristol Myers Squibb Co~$1.68BCut · 1.3% → 1.1%−26,185,727 shares
- Boston Scientific Corp~$781.0MCut · 0.5% → 0.3%−17,270,743 shares
- Seattle Genetics Inc~$636.1MCut · 0.3% → 0.2%−5,567,321 shares
- Nike Inc~$595.1MCut · 0.6% → 0.5%−5,874,242 shares
- Expedia Group Inc~$513.9MCut · 0.3% → 0.1%−4,752,124 shares
- Lennar Corp~$498.2MCut · 0.2% → 0.1%−8,929,911 shares
- Bb&T Corp~$495.8MSold out · 0.1% → 0.0%−9,290,509 shares
- Medtronic Plc~$490.3MCut · 1.8% → 1.6%−4,321,328 shares
- Eaton Corp Plc~$490.1MCut · 0.4% → 0.3%−5,173,878 shares
- Dupont De Nemours Inc~$473.6MCut · 0.1% → 0.0%−7,376,891 shares
Holdings
As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −0.6% · price +13.4% | 2.4% | $11.44B | +$1.35B | ||||||||
| Unitedhealth Group IncCOM · shares +7.5% · price +35.3% | 2.0% | $9.60B | +$2.33B | ||||||||
| Jpmorgan Chase & CoCOM · shares +4.0% · price +18.4% | 1.8% | $8.40B | +$1.26B | ||||||||
| Bank Amer CorpCOM · shares −0.7% · price +20.7% | 1.7% | $8.21B | +$1.41B | ||||||||
| Medtronic PlcSHS · shares −5.9% · price +4.4% | 1.6% | $7.80B | +$332.2M | ||||||||
| Pfizer IncCOM · shares +11% · price +9.0% | 1.6% | $7.59B | +$567.9M | ||||||||
| Verizon Communications IncCOM · shares −2.6% · price +1.7% | 1.4% | $6.88B | +$116.6M | ||||||||
| AppleCOM · shares +64% · price +31.1% | 1.4% | $6.69B | +$965.9M | ||||||||
| Eli LillyCOM · shares +12% · price +17.5% | 1.2% | $5.83B | +$777.4M | ||||||||
| Comcast Corp NewCL A · shares −4.2% · price −0.2% | 1.1% | $5.39B | −$13.2M | ||||||||
| AlphabetCAP STK CL A · shares −4.3% · price +9.7% | 1.1% | $5.36B | +$473.3M | ||||||||
| Bristol Myers Squibb CoCOM · shares −24% · price +26.6% | 1.1% | $5.36B | +$1.13B | ||||||||
| Merck & Co IncCOM · shares −1.9% · price +8.0% | 1.1% | $5.15B | +$383.6M | ||||||||
| Coca Cola CoCOM · shares −0.6% · price +1.7% | 1.1% | $5.11B | +$84.1M | ||||||||
| Chevron Corp NewCOM · shares −0.4% · price +1.6% | 0.95% | $4.53B | +$71.7M | ||||||||
| Lockheed Martin CorpCOM · shares −2.3% · price −0.2% | 0.93% | $4.44B | −$7.8M | ||||||||
| Chubb LimitedCOM · shares −8.9% · price −3.6% | 0.91% | $4.33B | −$160.8M | ||||||||
| Tjx Cos Inc NewCOM · shares +2.6% · price +9.5% | 0.86% | $4.09B | +$347.9M | ||||||||
| Home Depot IncCOM · shares −7.3% · price −5.9% | 0.86% | $4.09B | −$255.6M | ||||||||
| Mcdonalds CorpCOM · shares +42% · price −8.0% | 0.86% | $4.09B | −$249.0M | ||||||||
| Johnson & JohnsonCOM · shares +5.8% · price +12.7% | 0.84% | $4.02B | +$430.1M | ||||||||
| American TowerCOM · shares −4.6% · price +3.9% | 0.84% | $4.01B | +$151.7M | ||||||||
| IntelCOM · shares −2.7% · price +16.1% | 0.84% | $4.00B | +$556.3M | ||||||||
| AmazonCOM · shares −9.0% · price +6.4% | 0.84% | $3.99B | +$241.4M | ||||||||
| Union Pacific CorpCOM · shares +2.3% · price +11.6% | 0.82% | $3.89B | +$395.5M | ||||||||
| Total · 2,001 positions | 100% | $477.16B | +$34.25B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2019 to Q4 2019: 1,722 stocks held throughout, up $34.25B (+8.3%).
- Unitedhealth Group Inc+$2.33B+35%
- Bank Amer Corp+$1.41B+21%
- Microsoft+$1.35B+13%
- Jpmorgan Chase & Co+$1.26B+18%
- Bristol Myers Squibb Co+$1.13B+27%
- Chubb Limited−$160.8M−4%
- Public Storage−$198.3M−13%
- Mcdonalds Corp−$249.0M−8%
- Home Depot Inc−$255.6M−6%
- Medicines Co1:26 split−$517.2M−93%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |